Health

Clinical trials in Texas lead to therapeutic treatment

Austin, Texas — Vaccination is the front-line defense against COVID-19, and infusion centers are emerging throughout the state to treat COVID.

There are other options that will be available to Texas people in the fight against the virus, and some of the major research on these treatments is being done here in Texas.

Mike Woods lives in Austin, but he spends a lot of time traveling for work. He took a break from the heat of Texas, tied his skates, and struck ice to “train” a bit with his friends.

“This sounds like something cool,” Woods said.

This was an activity I couldn’t do when I got my COVID last year. Instead, he volunteered for his sick body for science. Woods was part of a clinical trial of monoclonal antibody therapy and was a simple procedure consisting of an hour of IV infusion.

“They do all the lab work and everything, they do it at home,” he said.

After injecting the monoclonal antibody, the nurse came to his house and examined his blood. This was a double-blind study, and neither the nurse nor Woods knew if they had been given a placebo.

“It was probably one of the best medical experiences I’ve had for a long time,” he said.

Dr. Robert Gottlieb is the person behind the study.

“Many patients with COVID wanted to feel like they were helping others,” he said.

He is a Principal Investigator for the COVID-19 treatment trial at Baylor Scott and White in Dallas.

“Exams are absolutely crucial, especially early on,” said Dr. Gottlieb.

He says these clinical trials have shown that treatment reduces the risk of severe symptoms, hospitalization, and in some cases death.

“You can reduce the risk of hospitalization by about 87%,” he said.

The FDA has approved three major manufacturers for emergency use authorization.

“This not only maintains our ability to maintain fairness at this point, but also keeps us one step ahead of the virus,” said Dr. Gottlieb.

The problem is that this work is labor-intensive and the supply is limited because treatment is widespread throughout the United States. This is partly due to the use of monoclonal antibody therapy instead of the vaccine, which is the first line of defense against COVID.

“One ounce of prevention is worth a pound of treatment,” he said.

Dr. Gottlieb says antibody therapy interferes with the response to vaccination, so patients must wait 90 days for treatment to leave the body before being vaccinated. People are eligible for monoclonal treatment even if they have already been vaccinated and infected with COVID.

Governor Greg Abbott’s office announces the location of a new infusion center almost every day. Hospitals like clinics, public health centers and Baylor Scott & White are one of many facilities that offer this treatment. You can find a place near you here.

And all this is possible thanks to volunteers like Woods.

“It’s almost like giving back,” he said. “If people can’t evaluate these different treatments without volunteering or stepping up, how do they know what works and what doesn’t?”

He’s still waiting to know if he’s been treated or placedbo, but it’s all smooth skating that he knows he was able to make a difference.

Clinical trials in Texas lead to therapeutic treatment

Source link Clinical trials in Texas lead to therapeutic treatment

Back to top button